SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023919
Filing Date
2022-11-09
Accepted
2022-11-09 16:29:40
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-20220930.htm   iXBRL 10-Q 3471296
2 EX-10.1 rptx-ex10_1.htm EX-10.1 30032
3 EX-10.2 rptx-ex10_2.htm EX-10.2 26263
4 EX-31.1 rptx-ex31_1.htm EX-31.1 20963
5 EX-31.2 rptx-ex31_2.htm EX-31.2 21256
6 EX-32.1 rptx-ex32_1.htm EX-32.1 10691
7 EX-32.2 rptx-ex32_2.htm EX-32.2 10879
  Complete submission text file 0000950170-22-023919.txt   9456043

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rptx-20220930_pre.xml EX-101.PRE 252777
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rptx-20220930_lab.xml EX-101.LAB 361471
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rptx-20220930.xsd EX-101.SCH 40553
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rptx-20220930_def.xml EX-101.DEF 116273
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rptx-20220930_cal.xml EX-101.CAL 41110
53 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20220930_htm.xml XML 1752984
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 221373109
SIC: 2834 Pharmaceutical Preparations